Rankings
▼
Calendar
PRME FY 2021 Earnings — Prime Medicine, Inc. Revenue & Financial Results | Market Cap Arena
PRME
Prime Medicine, Inc.
$771M
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
$0
Operating Income
-$84M
Net Income
-$165M
EPS (Diluted)
$-1.92
Cash Flow
Operating Cash Flow
-$34M
Free Cash Flow
-$38M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$302M
Total Liabilities
$62M
Stockholders' Equity
$240M
Cash & Equivalents
$185M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$5M
-100.0%
Gross Profit
$0
$2M
-100.0%
Operating Income
-$84M
-$932,000
-8963.7%
Net Income
-$165M
-$3M
-4749.5%
← Q4 2020
All Quarters
Q1 2021 →